Literature DB >> 12584373

Treating hypertension - what are we to believe?

Edward D Frohlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12584373     DOI： 10.1056/NEJMe020179

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Facts and ideas from anywhere.

Authors:  William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-04

Review 2.  Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension.

Authors:  Jeffrey A Cutler; Barry R Davis
Journal:  Circulation       Date:  2008-05-20       Impact factor: 29.690

3.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

Review 4.  Indian guidelines on hypertension-IV (2019).

Authors:  Siddharth N Shah; Y P Munjal; Sandhya A Kamath; Gurpreet S Wander; Nihar Mehta; Sukumar Mukherjee; Ashok Kirpalani; Pritam Gupta; Hardik Shah; Ragini Rohatgi; Aspi R Billimoria; M Maiya; Mrinal Kanti Das; Kewal C Goswami; Rajan Sharma; Mohan M Rajapurkar; Rajeev Chawla; Banshi Saboo; Vivekanand Jha
Journal:  J Hum Hypertens       Date:  2020-05-19       Impact factor: 3.012

Review 5.  Management of diabetic and hypertensive cardiovascular disease.

Authors:  Edward D Frohlich; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

6.  Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?

Authors:  Claudio Pedone; Enrica Cecchi; Rosanna Matucci; Marco Pahor; Luciana Carosella; Roberto Bernabei; Alessandro Mugelli
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 7.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

8.  The ANBP2 and ALLHAT: conflicting or consistent?

Authors:  Jeffrey A Cutler
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

9.  Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.

Authors:  Walter Zidek; Joachim Schrader; Stephan Lüders; Stephan Matthaei; Christoph Hasslacher; Joachim Hoyer; Claudia Zemmrich; Peter Bramlage; Claus-Dieter Sturm; W Dieter Paar
Journal:  Cardiovasc Diabetol       Date:  2012-01-09       Impact factor: 9.951

10.  First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.

Authors:  Walter Zidek; Joachim Schrader; Stephan Lüders; Stephan Matthaei; Christoph Hasslacher; Joachim Hoyer; Peter Bramlage; Claus-Dieter Sturm; W Dieter Paar
Journal:  Cardiovasc Diabetol       Date:  2008-07-24       Impact factor: 9.951
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.